Kuros Biosciences's MagnetOs Granules cleared by FDA for expanded spinal indications

Kuros Biosciences AG / Key word(s): Miscellaneous Kuros Biosciences's MagnetOs Granules cleared by FDA for expanded spinal indications 03.02.2022 / 07:00 Rare clearance for bone graft for standalone use in spine based on human clinical data Clearance attained with evidence from Level 1 randomize...

Related Keywords

Zurich ,Züsz ,Switzerland ,United States ,Netherlands ,Swiss ,Kuros Biosciences Kuro ,Hans Herklots ,Michael Grau ,Kuros Biosciences ,Company Project Fusion ,Drug Administration ,News Service ,Swiss Exchange ,Magnetos Granules ,Chief Executive Officer ,Project Fusion ,Sci Advisors ,Kuros ,Iosciences ,G ,Key ,Iscellaneous ,Euros ,Iosciences S ,Magnetos ,Granules ,Fda ,Mare ,Clearance ,Level ,